Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis

Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis

<b>(1) Background</b>: Cognitive impairment (CI) begins early in the evolution of multiple sclerosis (MS) but may only become obvious in the later stages of the disease. Little data is available regarding predictive biomarkers for early, active cognitive decline in relapse remitting MS (...

Full description

Bibliographic Details
Main Authors: Vlad Eugen Tiu, Bogdan Ovidiu Popescu, Iulian Ion Enache, Cristina Tiu, Elena Terecoasa, Cristina Aura Panea
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Diagnostics
Subjects:
cognitive impairment
multiple sclerosis
predictive biomarkers
RRMS
cognitive decline
neurofilaments
Online Access:https://www.mdpi.com/2075-4418/12/11/2571

Internet

https://www.mdpi.com/2075-4418/12/11/2571

Similar Items